JACoW logo

Journals of Accelerator Conferences Website (JACoW)

JACoW is a publisher in Geneva, Switzerland that publishes the proceedings of accelerator conferences held around the world by an international collaboration of editors.


BiBTeX citation export for FRCDE2: Accelerator Production of Medical Radionuclides

@unpublished{cutler:napac2022-frcde2,
  author       = {C.S. Cutler and D. Kim and D. Medvedev},
  title        = {{Accelerator Production of Medical Radionuclides}},
% booktitle    = {Proc. NAPAC'22},
  booktitle    = {Proc. 5th Int. Particle Accel. Conf. (NAPAC'22)},
  language     = {english},
  intype       = {presented at the},
  series       = {International Particle Accelerator Conference},
  number       = {5},
  venue        = {Albuquerque, NM, USA},
  publisher    = {JACoW Publishing, Geneva, Switzerland},
  month        = {10},
  year         = {2022},
  note         = {presented at NAPAC'22 in Albuquerque, NM, USA, unpublished},
  abstract     = {{Since 1931 major advances have enabled the production of small compact cyclotrons to be installed at hospitals and pharmacies enabling the supply of short-lived radionuclides around the world. This and the development of the generator allowed for remote access to radionuclides and the expansion of nuclear medicine. In the 1970’s and 80’s major accelerator facilities operating at 100 MeV and higher were installed in many of the national labs and used for production of radionuclides at energies and currents not available on the small compact machines. These high energy accelerators have played an important role in supplying Radionuclides such as Sr-82 used in Sr/Rb generators for cardiac imaging and Ac-225 for cancer therapy. They continue to be advanced to further production yields by installing beam rastering systems that have allowed higher intensities and thus higher production yields. As well as adding mass separation techniques that enable novel radionuclides to be produced in quality suitable for use. These enhanced accelerator capabilities and the production of these novel radionuclides will be presented.}},
}